![](https://tracker.live.rns-distribution.com/track.live-rns/4810552_75d1671758db0ed18eba2dbba83793b2.png)
22 June 2023
Quadrise Plc
("Quadrise" or the "Company")
Morocco Update
Quadrise Plc (AIM:QED), the supplier of innovative energy solutions for a cleaner planet, provides an update on its fuel trial in Morocco following the announcement on 22 May 2023.
The previous demonstration test at the client's site in Morocco was paused after a mechanical component in the fuel delivery system failed progressively. The parties agreed to resume the trial once replacement parts could be sourced.
Quadrise is pleased to announce that the necessary parts and spares have been delivered to Morocco. Our personnel have installed the parts, re-tested the fuel delivery system and are ready to recommence the trial at the next available opportunity.
For additional information, please contact:
Quadrise Plc | | +44 (0)20 7031 7321 |
Andy Morrison, Chairman Jason Miles, Chief Executive Officer | | |
| | |
Nominated Adviser | | |
Cenkos Securities plc | | +44 (0)20 7397 8900 |
Ben Jeynes | | |
Katy Birkin | | |
Joint Brokers Shore Capital Stockbrokers Limited | |
+44 (0)20 7408 4090 |
Toby Gibbs, Rachel Goldstein (Corporate Advisory) | | |
Fiona Conroy (Corporate Broking) | | |
|
|
|
VSA Capital Limited Andrew Raca (Corporate Finance) Andrew Monk (Corporate broking) | | +44 (0)20 3005 5000 |
| | |
Public & Investor Relations |
|
|
Vigo Consulting Patrick D'Ancona Charlie Neish | | +44 (0)20 7390 0230 |
About Quadrise
Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.
Learn more at: www.quadrise.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.